We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

129 hedge funds and large institutions have $715M invested in PTC Therapeutics in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

66% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 32

16% more capital invested

Capital invested by funds: $615M → $715M (+$101M)

13% more funds holding

Funds holding: 114 → 129 (+15)

5.05% more ownership

Funds ownership: 81.32% → 86.37% (+5.1%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

52% less call options, than puts

Call options by funds: $41.2M | Put options by funds: $86.1M

Holders
129
Holders Change
+15
Holders Change %
+13.16%
% of All Funds
3.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
29
Increased
53
Reduced
32
Closed
13
Calls
$41.2M
Puts
$86.1M
Net Calls
-$44.9M
Net Calls Change
-$54.1M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$23.4M
2
DAM
DLD Asset Management
New York
+$12M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
4
NI
Numeric Investors
Massachusetts
+$9.22M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.89M

Top Sellers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
-$20.8M
2
GPP
Great Point Partners
Connecticut
-$15.7M
3
Morgan Stanley
Morgan Stanley
New York
-$9.26M
4
CCM
Camber Capital Management
Massachusetts
-$9.16M
5
BC
Boxer Capital
California
-$8.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ohio Public Employees Retirement System (OPERS)
101
Ohio Public Employees Retirement System (OPERS)
Ohio
$232K +$75.1K +3,835 +50%
Los Angeles Capital Management
102
Los Angeles Capital Management
California
$229K +$224K +11,460 New
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$219K +$200K +10,209 +1,338%
Nisa Investment Advisors
104
Nisa Investment Advisors
Missouri
$200K – – –
ACM
105
Advent Capital Management
New York
$200K +$196K +10,000 New
Russell Investments Group
106
Russell Investments Group
United Kingdom
$191K – – –
Legal & General Group
107
Legal & General Group
United Kingdom
$186K +$25.5K +1,302 +16%
Public Employees Retirement Association of Colorado
108
Public Employees Retirement Association of Colorado
Colorado
$160K – – –
QT
109
Quantbot Technologies
New York
$150K +$147K +7,502 New
Macquarie Group
110
Macquarie Group
Australia
$102K +$99.8K +5,100 New
CSS
111
Cubist Systematic Strategies
Connecticut
$93K +$64.5K +3,294 +241%
BNP Paribas Financial Markets
112
BNP Paribas Financial Markets
France
$79.9K -$5.17K -264 -6%
Canada Life
113
Canada Life
Manitoba, Canada
$73K – – –
AIP
114
Ameritas Investment Partners
Nebraska
$54K – – –
Federated Hermes
115
Federated Hermes
Pennsylvania
$51K -$30K -1,534 -38%
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$27K +$13.6K +696 +103%
SEI Investments
117
SEI Investments
Pennsylvania
$22K +$2.25K +115 +12%
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
$18K -$511K -26,091 -97%
LTFS
119
Ladenburg Thalmann Financial Services
Florida
$18K -$198K -10,107 -92%
TRCT
120
Tower Research Capital (TRC)
New York
$11K +$10.8K +554 New
AG
121
Advisor Group
Arizona
$10K – – –
MAM
122
Meeder Asset Management
Ohio
$8K +$6.54K +334 +682%
AWMS
123
Advocacy Wealth Management Services
Georgia
$7K – – –
LJHT
124
Laurie J. Hall Trustee
$2.4K – – –
IA
125
IFP Advisors
Florida
$2K – – –
2 3 4
5
6

PTCT Hedge Fund Activity: Q3 2017 in Review

129 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q3 2017, worth a combined $715M — up 16% from $615M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PTCT positions and 13 closed out — a net gain of 16 holders — while 53 added to existing stakes and 32 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $23.4M. The largest seller was Frontier Capital Management, cutting an estimated $20.8M.

  • 129 institutional investors held PTC Therapeutics (PTCT) as of Q3 2017, up from 114 in Q2 2017.
  • Funds reported $715M of PTC Therapeutics stock for Q3 2017, up 16% quarter-over-quarter.
  • 29 funds opened new PTC Therapeutics positions in Q3 2017 and 13 closed out, a net change of +16 holders.
  • The largest PTC Therapeutics buyer in Q3 2017 was Scopia Capital Management, an estimated $23.4M added.
  • The largest PTC Therapeutics seller in Q3 2017 was Frontier Capital Management, an estimated $20.8M sold.

Based on aggregated 13F filings for Q3 2017.